421 related articles for article (PubMed ID: 19863225)
1. Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience.
Brandal P; Bjerkehagen B; Bruland OS; Skjeldal S; Bogsrud TV; Hall KS
Acta Oncol; 2009; 48(8):1165-72. PubMed ID: 19863225
[TBL] [Abstract][Full Text] [Related]
2. Single and multiple metachronous osteosarcoma tumors after therapy.
Jaffe N; Pearson P; Yasko AW; Lin P; Herzog C; Raymond K
Cancer; 2003 Dec; 98(11):2457-66. PubMed ID: 14635081
[TBL] [Abstract][Full Text] [Related]
3. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
4. Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients.
Wu PK; Chen WM; Chen CF; Lee OK; Haung CK; Chen TH
Jpn J Clin Oncol; 2009 Aug; 39(8):514-22. PubMed ID: 19525290
[TBL] [Abstract][Full Text] [Related]
5. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features, treatment, and prognosis of postirradiation osteosarcoma in patients with nasopharyngeal cancer.
Wei-wei L; Qiu-liang W; Guo-hao W; Zhi-hua C; Zong-yuan Z
Laryngoscope; 2005 Sep; 115(9):1574-9. PubMed ID: 16148697
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma.
McTiernan A; Meyer T; Michelagnoli MP; Lewis I; Whelan JS
Pediatr Blood Cancer; 2006 Mar; 46(3):345-50. PubMed ID: 16206197
[TBL] [Abstract][Full Text] [Related]
8. Bilateral Wilms' tumor: Mansoura multi-centers 15 years experience.
Halim A; Elashry R; Soliman O; Sarhan O
J Oncol Pharm Pract; 2012 Mar; 18(1):115-21. PubMed ID: 22235062
[TBL] [Abstract][Full Text] [Related]
9. Comparison of primary osteosarcoma of flat bones with secondary osteosarcoma of any site.
Pratt CB; Meyer WH; Rao BN; Pappo AS; Fleming ID; Luo X; Cain A; Kaste SC; Shearer PD; Jenkins JJ
Cancer; 1997 Sep; 80(6):1171-7. PubMed ID: 9305720
[TBL] [Abstract][Full Text] [Related]
10. Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma.
Hauben EI; Arends J; Vandenbroucke JP; van Asperen CJ; Van Marck E; Hogendoorn PC
Eur J Hum Genet; 2003 Aug; 11(8):611-8. PubMed ID: 12891382
[TBL] [Abstract][Full Text] [Related]
11. [High grade osteosarcoma of the lower limb. Complications and results of the treatment of 20 patients].
Babin SR; Simon P; Babin-Boilletot A; Bellocq JP; Marcellin L; Dosch JC
Rev Chir Orthop Reparatrice Appar Mot; 1996; 82(1):14-21. PubMed ID: 8762984
[TBL] [Abstract][Full Text] [Related]
12. Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001.
Holzbeierlein JM; Sogani PC; Sheinfeld J
J Urol; 2003 Jun; 169(6):2122-5. PubMed ID: 12771732
[TBL] [Abstract][Full Text] [Related]
13. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
14. Multicentric osteosarcoma: clinicopathologic and radiographic study of 56 cases.
Corradi D; Wenger DE; Bertoni F; Bacchini P; Bosio S; Goldoni M; Unni KK; Sim FH; Inwards CY
Am J Clin Pathol; 2011 Nov; 136(5):799-807. PubMed ID: 22031320
[TBL] [Abstract][Full Text] [Related]
15. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
Bielack SS; Kempf-Bielack B; Heise U; Schwenzer D; Winkler K
J Clin Oncol; 1999 Apr; 17(4):1164. PubMed ID: 10561175
[TBL] [Abstract][Full Text] [Related]
16. Extraosseous osteosarcoma: single institutional experience in Korea.
Lee S; Lee MR; Lee SJ; Ahn HK; Yi J; Yi SY; Seo SW; Sung KS; Park JO; Lee J
Asia Pac J Clin Oncol; 2010 Jun; 6(2):126-9. PubMed ID: 20565425
[TBL] [Abstract][Full Text] [Related]
17. [Low grade intramedullary osteosarcoma. Apropos of 8 cases].
Katabi M; Anract P; Forest M; Tomeno B
Rev Chir Orthop Reparatrice Appar Mot; 1996; 82(3):208-15. PubMed ID: 9005458
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome of osteosarcoma after bilateral retinoblastoma: a retrospective study of eight cases.
Lee JA; Choi SY; Kang HJ; Lee JW; Kim H; Kim JH; Sung KW; Shin HY; Ahn HS; Park KD
Br J Ophthalmol; 2014 Oct; 98(10):1355-9. PubMed ID: 24795337
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
